Total Payments
$5,022
2024 Payments
$113.78
Companies
29
Transactions
173
Medicare Patients
2,200
Medicare Billing
$264,626
Payment Breakdown by Category
Food & Beverage$4,907 (97.7%)
Education$99.99 (2.0%)
Other$14.83 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,907 | 171 | 97.7% |
| Education | $99.99 | 1 | 2.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14.83 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $1,165 | 22 | $0 (2024) |
| GENZYME CORPORATION | $812.56 | 29 | $0 (2019) |
| UCB, Inc. | $535.38 | 13 | $0 (2021) |
| Amgen Inc. | $377.55 | 15 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $272.03 | 4 | $0 (2022) |
| Mallinckrodt Enterprises LLC | $257.45 | 7 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $240.67 | 23 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $226.14 | 10 | $0 (2020) |
| Genentech USA, Inc. | $192.35 | 7 | $0 (2019) |
| Supernus Pharmaceuticals, Inc. | $135.51 | 5 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $113.78 | 6 | Lilly USA, LLC ($37.96) |
| 2023 | $207.26 | 4 | Eisai Inc. ($122.10) |
| 2022 | $56.25 | 3 | Teva Pharmaceuticals USA, Inc. ($23.12) |
| 2021 | $409.61 | 20 | AbbVie Inc. ($111.74) |
| 2020 | $46.08 | 3 | Amgen Inc. ($19.01) |
| 2019 | $1,261 | 52 | GENZYME CORPORATION ($294.49) |
| 2018 | $1,524 | 58 | GENZYME CORPORATION ($518.07) |
| 2017 | $1,404 | 27 | Biogen, Inc. ($655.54) |
All Payment Transactions
173 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/16/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Neuroscience | ||||||
| 08/22/2024 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Neurology | ||||||
| 08/17/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Neuroscience | ||||||
| 04/18/2024 | Biogen, Inc. | QALSODY (Drug), SPINRAZA | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Neurology | ||||||
| 01/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/05/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: Neurology | ||||||
| 10/27/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $122.10 | General |
| Category: Neurology | ||||||
| 07/07/2023 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | Cash or cash equivalent | $38.90 | General |
| Category: Neurology | ||||||
| 04/18/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/14/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/21/2022 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Rare Disease | ||||||
| 02/07/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Central Nervous System | ||||||
| 01/19/2022 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $20.35 | General |
| 09/24/2021 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Neurology | ||||||
| 09/08/2021 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 08/27/2021 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $22.00 | General |
| 08/26/2021 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Neurology | ||||||
| 08/10/2021 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: NEUROLOGY | ||||||
| 07/07/2021 | AbbVie Inc. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $28.21 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: PRIMARY CARE | ||||||
| 06/10/2021 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: Neurology | ||||||
| 05/20/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2021 | AbbVie Inc. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: NEUROSCIENCE | ||||||
| 05/06/2021 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $18.76 | General |
| 04/29/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 257 | 301 | $119,180 | $27,904 |
| 2022 | 10 | 358 | 407 | $106,553 | $34,749 |
| 2021 | 13 | 760 | 979 | $667,933 | $92,807 |
| 2020 | 18 | 825 | 1,077 | $957,006 | $109,167 |
Total Patients
2,200
Total Services
2,764
Medicare Billing
$264,626
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 51 | 52 | $21,868 | $7,124 | 32.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 48 | 50 | $21,310 | $5,709 | 26.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 33 | 45 | $39,802 | $4,956 | 12.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 45 | 62 | $11,856 | $3,898 | 32.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 25 | $6,290 | $2,398 | 38.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $5,600 | $1,793 | 32.0% |
| 95812 | Measurement of brain wave activity (eeg), 41-60 minutes | Facility | 2023 | 25 | 26 | $2,600 | $1,142 | 43.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 12 | 13 | $8,606 | $673.27 | 7.8% |
| 99446 | Telephone, internet, or electronic health record assessment and management with verbal and written report by consulting physician, 5-10 minutes | Facility | 2023 | 12 | 12 | $1,248 | $210.60 | 16.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 73 | 73 | $30,489 | $11,557 | 37.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 84 | 104 | $17,843 | $5,883 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 69 | 90 | $12,995 | $5,631 | 43.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 40 | 40 | $12,292 | $4,215 | 34.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 23 | $4,995 | $2,140 | 42.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 16 | $12,446 | $1,591 | 12.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $4,355 | $1,474 | 33.9% |
| 95812 | Measurement of brain wave activity (eeg), 41-60 minutes | Facility | 2022 | 19 | 21 | $2,100 | $969.05 | 46.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 14 | 15 | $7,760 | $744.56 | 9.6% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 11 | 12 | $1,278 | $543.08 | 42.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 158 | 161 | $67,664 | $26,258 | 38.8% |
| 95913 | Nerve transmission studies, 13 or more studies | Office | 2021 | 47 | 54 | $351,000 | $13,496 | 3.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 132 | 196 | $36,869 | $11,019 | 29.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 90 | 97 | $24,463 | $10,212 | 41.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 54 | 102 | $35,700 | $8,990 | 25.2% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 46 | 106 | $106,000 | $8,901 | 8.4% |
About Syed Ali
Syed Ali is a Neurology healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1396733713.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Syed Ali has received a total of $5,022 in payments from pharmaceutical and medical device companies, with $113.78 received in 2024. These payments were reported across 173 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($4,907).
As a Medicare-enrolled provider, Ali has provided services to 2,200 Medicare beneficiaries, totaling 2,764 services with total Medicare billing of $264,626. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology, Neurology
- Location Fort Worth, TX
- Active Since 10/10/2005
- Last Updated 05/15/2024
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1396733713
Products in Payments
- TYSABRI (Biological) $532.40
- TECFIDERA (Drug) $456.27
- LEMTRADA (Drug) $443.36
- Briviact (Drug) $421.05
- AUBAGIO (Drug) $369.20
- Aimovig (Biological) $358.96
- ACTHAR (Biological) $257.45
- APTIOM (Drug) $240.67
- AUSTEDO (Drug) $162.33
- TROKENDI XR (Drug) $129.03
- Leqembi (Drug) $122.10
- Vimpat (Drug) $114.33
- AJOVY (Drug) $109.70
- Esbriet (Biological) $99.99
- OCREVUS (Biological) $92.36
- MAYZENT (Drug) $78.23
- XARELTO (Drug) $75.83
- EMGALITY (Drug) $75.46
- UBRELVY (Drug) $62.84
- NURTEC ODT (Drug) $50.06
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Fort Worth
Dr. Hamid Kadiwala, M.d, M.D
Neurology — Payments: $139,323
Neurology $139,323
Horacio Chiong-Rivero, M.d., Ph.d, M.D., PH.D
Neurology — Payments: $83,086
Neurology $83,086
Sharique Ansari, M.d., Mph, M.D., MPH
Neurology — Payments: $79,831
Neurology $79,831
Krishnababu Chunduri, Md, MD
Neurology — Payments: $41,859
Neurology $41,859
Leila Bostan Shirin, M.d, M.D
Neurology — Payments: $35,690
Neurology $35,690
Jiangping Liu, Md, MD
Neurology — Payments: $33,262
Neurology $33,262